SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

01 Nov 2025 Evaluate
The revenue for the September 2025 quarter is pegged at Rs. 664.00 millions, about 8.14% up against Rs. 614.00 millions recorded during the year-ago period.The Net Loss for the quarter ended September 2025 is Rs. -480.00 millions as compared to Net Profit of Rs. 143.00 millions of corresponding quarter ended September 2024Operating Profit reported a sharp decline to 126.00 millions from 295.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 664.00 614.00 8.14 1259.00 1146.00 9.86 7457.00 7847.00 -4.97
Other Income 8.00 195.00 -95.90 15.00 198.00 -92.42 996.00 1034.00 -3.68
PBIDT 126.00 295.00 -57.29 236.00 396.00 -40.40 1317.00 1199.00 9.84
Interest 25.00 32.00 -21.88 55.00 65.00 -15.38 298.00 299.00 -0.33
PBDT 101.00 263.00 -61.60 181.00 331.00 -45.32 907.00 900.00 0.78
Depreciation 16.00 17.00 -5.88 31.00 36.00 -13.89 531.00 483.00 9.94
PBT 85.00 246.00 -65.45 150.00 295.00 -49.15 376.00 417.00 -9.83
TAX 565.00 103.00 448.54 589.00 108.00 445.37 184.00 101.00 82.18
Deferred Tax 551.00 11.00 4909.09 563.00 16.00 3418.75 -14.00 33.00 -142.42
PAT -480.00 143.00 -435.66 -439.00 187.00 -334.76 192.00 316.00 -39.24
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 18.98 48.05 -60.50 18.75 34.55 -45.75 17.66 15.28 15.59

Jubilant Pharmova Share Price

944.45 -1.85 (-0.20%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×